Home
Conditions
Leukemia

Clinical trial condition

Leukemia

Explore clinical trials studying Leukemia. Study availability and eligibility vary by location and protocol.

4,419 public trials 1,034 recruiting studies

Refine in advanced search Browse all conditions

Leukemia trial results

Completed

SCT in Ph Positive Acute Lymphoblastic Leukemia

NCT03821727

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Immune System Diseases, +10 more
Locations: GITMO Centers and GITMO CLINICAL OFFICE-AOU-IRCSS San Martino-Ge Genova, Italy

University Hospital, Udine Udine, Italy

View Trial Details

Completed

Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia

NCT01807598

Conditions: Aggressive Systemic Mastocytosis, Hematologic Diseases, Hemic and Lymphatic Diseases, +14 more
Locations: Stanford University, School of Medicine Stanford, California, United States

MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Phase 1/2 Study of the ERK1/2 Inhibitor BVD-523 in Patients With Acute Myelogenous Leukemia or Myelodysplastic Syndromes

NCT02296242

Conditions: Acute Myelogenous Leukemia, Bone Marrow Diseases, Hematologic Diseases, +8 more
Locations: UCLA Medical Center Los Angeles, California, United States

Winship Cancer Institute of Emory University Atlanta, Georgia, United States

Roswell Park Cancer Institute Buffalo, New York, United States

Perelman Center for Advanced Medicine Philadelphia, Pennsylvania, United States

View Trial Details

Completed

CLL Empirical Antibiotic Regimen

NCT01279252

Conditions: Chronic Lymphocytic Leukaemia (CLL), Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations: King's College Hospital NHS Foundation Trust London, United Kingdom

View Trial Details

Completed

Pacritinib and Chemotherapy in Treating Patients With Acute Myeloid Leukemia and FLT3 Mutations

NCT02323607

Conditions: Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +8 more
Locations: Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States

View Trial Details

Completed

Clofarabine-cyclophosphamide as Salvage Therapy for Refractory and Relapsed Acute Lymphoblastic Leukemia (ALL) Adults

NCT01462253

Conditions: Acute Lymphoblastic Leukemia, Disease Attributes, Hematologic Diseases, +13 more
Locations: Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy

Divisione di Ematologia - Ospedali Riuniti Bergamo, Italy

Istituto di Ematologia "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy

Azienda Sanitaria di Bolzano - Ospedale Centrale - Ematologia e Centro TMO Bolzano, Italy

View all 27 locations

View Trial Details

Completed

Red Cell Transfusion Goals in Patients With Acute Leukemias

NCT02086773

Conditions: Acute Lymphoblastic Leukemia, Acute Lymphocytic Leukemia (ALL), Acute Myelogenous Leukemia (AML), +15 more
Locations: The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

NCT02208037

Conditions: Acute Leukemia, Anemia, Anemia, Refractory, +35 more
Locations: City of Hope National Medical Center Duarte, California, United States

Stanford Hospital and Clinics Stanford, California, United States

University of Florida College of Medicine (Shands) Gainesville, Florida, United States

H. Lee Moffitt Cancer Center Tampa, Florida, United States

View all 30 locations

View Trial Details

Completed

Donor Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies

NCT01093586

Conditions: Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Lymphoblastic Leukemia in Remission, Adult Acute Megakaryoblastic Leukemia (M7), +141 more
Locations: Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Completed

CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome

NCT02019069

Conditions: Adult Acute Erythroid Leukemia (M6), Adult Acute Megakaryoblastic Leukemia (M7), Adult Acute Minimally Differentiated Myeloid Leukemia (M0), +28 more
Locations: Stanford University, School of Medicine Stanford, California, United States

View Trial Details

Leukemia

Leukemia trial results

Related conditions